Business

OptimizeRx Sets Fourth Quarter and Full Year 2019 Conference Call for Thursday, February 27, 2020 at 4:30 p.m. ET

ROCHESTER, Mich., Feb. 19, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies

articleOptimizerx CorporationFebruary 19, 20204/company/optimizerx-corp/news/optimizerx-sets-fourth-quarter-and-full-year-2019-conference-call-for-thursday-february-27-2020-at-430-pm-et
OptimizeRx Sets Fourth Quarter and Full Year 2019 Conference Call for Thursday, February 27, 2020 at 4:30 p.m. ET

About this update from Optimizerx Corporation

[{"type":"text","content":"ROCHESTER, Mich., Feb. 19, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Thursday, February 27, 2020 at 4:30 p.m. Eastern time to discuss results for the fourth quarter and full year ended December 31, 2019. The financial results will be issued in a press release prior to the call.\n OptimizeRx management will host the call, followed by a question and answer period. Date: Thursday, February 27, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-888-220-8451International dial-in number: 1-323-794-2588Conference ID: 2951536 Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact CMA at 1-949-432-7566. A replay of the call will be available after 7:30 p.m. Eastern time on the same day through March 19, 2020, as well as available for replay via the Investors section of the OptimizeRx website at optimizerx.com/investors. Toll-free replay number: 1-844-512-2921International replay number: 1-412-317-6671Replay ID: 2951536 About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest digital platform connecting life sciences to the point-of-care, OptimizeRx provides a direct channel for pharma companies, payers, medtech, and medical associations to communicate with healthcare providers right within their workflow and directly to patients. The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest, and directly via its mobile communications digital care management platform. For more information, follow the company on Twitter, LinkedIn or visit www.OptimizeRx.com. Important Cautions Regarding Forward-Looking StatementsThis press rele...

More updates from Optimizerx Corporation